Regulation of osteoclast formation and function.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Inhibition of Neddylation Suppresses Osteoclast Differentiation and Function In Vitro and Alleviates Osteoporosis In Vivo.Biomedicines · 2022
   Article
2. Comparison of Synthetic vs. Biogenic Polymeric Process-Directing Agents for Intrafibrillar Mineralization of Collagen.Polymers · 2022
   Article
3. Age-related changes and reference intervals of RANKL, OPG, and bone turnover markers in Indian women.Archives of osteoporosis · 2021
   Article
4. Genetically-programmed, mesenchymal stromal cell-laden & mechanically strong 3D bioprinted scaffolds for bone repair.Journal of controlled release : official journal of the Controlled Release Society · 2020
   Article
5. The Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity.Frontiers in endocrinology · 2020
   Review
6. Pathophysiology of Osteonecrosis of the Jaws.Oral and maxillofacial surgery clinics of North America · 2015
   Review
7. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Oral diseases · 2015
   Review
8. Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts.Acta biomaterialia · 2014
   Article
9. Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.Bone · 2013
   Article
10. Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation.BoneKEy reports · 2012
    Article
11. In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2008
    Article
12. Osteoprotegerin as a potential therapy for osteoporosis.Current rheumatology reports · 2006
    Review
13. Osteoprotegerin as a potential therapy for osteoporosis.Current osteoporosis reports · 2005
    Review
14. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects.Cellular and molecular neurobiology · 2004
    Review
15. Primitive adult hematopoietic stem cells can function as osteoblast precursors.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
16. RANK ligand and the regulation of skeletal remodeling.The Journal of clinical investigation · 2003
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as